- Home
- IFRX vs VOC Comparison
IFRX vs VOC Comparison
Compare IFRX & VOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- VOC
- Stock Information
- Founded
- IFRX 2007
- VOC 2010
- Country
- IFRX Germany
- VOC United States
- Employees
- IFRX N/A
- VOC N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- VOC Oil & Gas Production
- Sector
- IFRX Health Care
- VOC Energy
- Exchange
- IFRX Nasdaq
- VOC Nasdaq
- Market Cap
- IFRX 53.5M
- VOC 51.3M
- IPO Year
- IFRX 2017
- VOC 2011
- Fundamental
- Price
- IFRX $1.14
- VOC $2.89
- Analyst Decision
- IFRX Strong Buy
- VOC
- Analyst Count
- IFRX 5
- VOC 0
- Target Price
- IFRX $7.40
- VOC N/A
- AVG Volume (30 Days)
- IFRX 1.0M
- VOC 52.9K
- Earning Date
- IFRX 11-07-2025
- VOC 01-01-0001
- Dividend Yield
- IFRX N/A
- VOC 21.63%
- EPS Growth
- IFRX N/A
- VOC N/A
- EPS
- IFRX N/A
- VOC 0.57
- Revenue
- IFRX $191,224.00
- VOC $11,024,911.00
- Revenue This Year
- IFRX N/A
- VOC N/A
- Revenue Next Year
- IFRX $1,216.24
- VOC N/A
- P/E Ratio
- IFRX N/A
- VOC $4.83
- Revenue Growth
- IFRX 54.36
- VOC N/A
- 52 Week Low
- IFRX $0.71
- VOC $2.44
- 52 Week High
- IFRX $2.82
- VOC $5.69
- Technical
- Relative Strength Index (RSI)
- IFRX 45.40
- VOC 62.38
- Support Level
- IFRX $1.45
- VOC $2.64
- Resistance Level
- IFRX $1.77
- VOC $2.76
- Average True Range (ATR)
- IFRX 0.21
- VOC 0.07
- MACD
- IFRX -0.04
- VOC 0.03
- Stochastic Oscillator
- IFRX 24.94
- VOC 96.19
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About VOC VOC Energy Trust Units of Beneficial Interest
VOC Energy Trust is a statutory trust. It is created to acquire and hold a term net profits interest for the benefit of the Trust unitholders. The underlying properties include VOC Brazos' net interests which are located in the states of Kansas and Texas. The trust is entitled to receive the net proceeds from the sale of production of oil and natural gas attributable to the underlying properties. The business and affairs of the Trust are managed by the Trustee, and neither VOC Brazos nor any of its affiliates has the ability to manage or influence the operations of the Trust.